The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies

Motor and nonmotor heterogeneity of LRRK2 -related and idiopathic Parkinson's disease

(2016) Connie Marras et al.   MOVEMENT DISORDERS

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease

(2015) Alberto Bergareche et al.   MOVEMENT DISORDERS

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in theLRRK2gene

(2015) Anat Mirelman et al.   MOVEMENT DISORDERS

REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers

(2015) Rachel Saunders-Pullman et al.   MOVEMENT DISORDERS

Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium

(2015) Karen Marder et al.   NEUROLOGY

Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease

(2015) Lorraine V. Kalia et al.   JAMA Neurology

Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers

(2015) Claustre Pont-Sunyer et al.   PLoS One

Olfactory identification inLRRK2G2019S mutation carriers: a relevant marker?

(2015) Rachel Saunders-Pullman et al.   Annals of Clinical and Translational Neurology

Comparing the accuracy of different smell identification tests in Parkinson’s disease: Relevance of cultural aspects

(2014) Mayela Rodríguez-Violante et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants

(2014) Roy N. Alcalay et al.   GENETICS IN MEDICINE

Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers

(2014) R. C. Helmich et al.   NEUROLOGY

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease

(2014) Carles Gaig et al.   PLoS One

A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism

(2013) Joanne Trinh et al.   NEUROBIOLOGY OF AGING

Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease

(2013) M. Sierra et al.   NEUROLOGY

Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism

(2012) B. F. L. van Nuenen et al.   BRAIN

Gait alterations in healthy carriers of the LRRK2 G2019S mutation

(2011) Anat Mirelman et al.   ANNALS OF NEUROLOGY

123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations

(2011) Francesc Valldeoriola et al.   JOURNAL OF NEUROLOGY

Progress in defining the premotor phase of Parkinson's disease

(2011) Eduardo Tolosa et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers

(2011) Kathrin Brockmann et al.   MOVEMENT DISORDERS

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations

(2011) Javier Ruiz-Martínez et al.   MOVEMENT DISORDERS

Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers

(2011) C. Marras et al.   NEUROLOGY

Olfactory dysfunction in LRRK2 G2019S mutation carriers

(2011) R. Saunders-Pullman et al.   NEUROLOGY

Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease

(2011) Soraya Bardien et al.   PARKINSONISM & RELATED DISORDERS

Subclinical signs in LRRK2 mutation carriers

(2011) Krisztina K. Johansen et al.   PARKINSONISM & RELATED DISORDERS

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)

(2010) Javier Ruiz-Martínez et al.   MOVEMENT DISORDERS

LRRK2 G2019S mutation in Parkinson’s disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort

(2010) Soreya Belarbi et al.   PARKINSONISM & RELATED DISORDERS

Neuropathology of Parkinson's disease with the R1441G mutation inLRRK2

(2009) José-Félix Martí-Massó et al.   MOVEMENT DISORDERS

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

(2008) Daniel G Healy et al.   LANCET NEUROLOGY